253 related articles for article (PubMed ID: 28858296)
1. CCN3 suppresses TGF-β1-induced extracellular matrix accumulation in human mesangial cells in vitro.
Liu HF; Liu H; Lv LL; Ma KL; Wen Y; Chen L; Liu BC
Acta Pharmacol Sin; 2018 Feb; 39(2):222-229. PubMed ID: 28858296
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
3. [Effect of PKC signalling pathway and aldose reductase on expression of fibronectin induced by transforming growth factor-β1 in human mesangial cells].
Huang P; Zhang YJ; Huang Y; Zhao JJ; Jiang T; Zhang N
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):405-9. PubMed ID: 21055159
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
Shek FW; Benyon RC; Walker FM; McCrudden PR; Pender SL; Williams EJ; Johnson PA; Johnson CD; Bateman AC; Fine DR; Iredale JP
Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
[TBL] [Abstract][Full Text] [Related]
6. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
7. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.
Hu W; Han Q; Zhao L; Wang L
J Cell Physiol; 2019 Feb; 234(2):1469-1476. PubMed ID: 30054916
[TBL] [Abstract][Full Text] [Related]
9. DPP8/9 inhibition attenuates the TGF-β1-induced excessive deposition of extracellular matrix (ECM) in human mesangial cells via Smad and Akt signaling pathways.
Li K; Zhang Y; Zhao W; Wang R; Li Y; Wei L; Wang L; Chen X; Chen Z; Liu P; Nie N; Tian X; Fu R
Toxicol Lett; 2024 May; 395():1-10. PubMed ID: 38458339
[TBL] [Abstract][Full Text] [Related]
10. [Effects of p38 MAPK signaling pathway and aldose reductase on transforming growth factor-β1 induced expression of fibronectin in cultured human mesangial cells].
Huang P; Zhang Y; Jiang T; Zhang N
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):778-82. PubMed ID: 26888387
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 ameliorates high glucose-induced fibrogenesis in mesangial cells through inhibiting STAT5 signaling pathway.
Li S; Guo X; Zhang T; Wang N; Li J; Xu P; Zhang S; Ren G; Li D
Biomed Pharmacother; 2017 Sep; 93():695-704. PubMed ID: 28692941
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.
Chen X; Jiang D; Wang J; Chen X; Xu X; Xi P; Fan Y; Zhang X; Guan Y
Int J Mol Med; 2015 Jan; 35(1):285-93. PubMed ID: 25352206
[TBL] [Abstract][Full Text] [Related]
15. Relaxin Inhibits High Glucose-Induced Matrix Accumulation in Human Mesangial Cells by Interfering with TGF-β1 Production and Mesangial Cells Phenotypic Transition.
Xie X; Xia W; Fei X; Xu Q; Yang X; Qiu D; Wang M
Biol Pharm Bull; 2015; 38(10):1464-9. PubMed ID: 26424011
[TBL] [Abstract][Full Text] [Related]
16. Role of TGF-beta1, extracellular matrix, and matrix metalloproteinase in the healing process of the pancreas after induction of acute necrotizing pancreatitis using arginine in rats.
Kihara Y; Tashiro M; Nakamura H; Yamaguchi T; Yoshikawa H; Otsuki M
Pancreas; 2001 Oct; 23(3):288-95. PubMed ID: 11590325
[TBL] [Abstract][Full Text] [Related]
17. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
Singh R; Song RH; Alavi N; Pegoraro AA; Singh AK; Leehey DJ
Exp Nephrol; 2001; 9(4):249-57. PubMed ID: 11423724
[TBL] [Abstract][Full Text] [Related]
18. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
[TBL] [Abstract][Full Text] [Related]
19. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes.
Yao M; Wang X; Wang X; Zhang T; Chi Y; Gao F
Int J Mol Med; 2015 Jul; 36(1):294-300. PubMed ID: 25902289
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
